Institutional Ownership Ovid Therapeutics Inc. (OVID)
This table provides information about the institutional ownership of Ovid Therapeutics Inc. (OVID). We have compiled data on the 85 institutions that hold shares in the stock, with a total of 40 Million shares, which have been reported (via 13F filing form) to have a value of $24.4 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
135,487
shares
|
$82,647
0.0% of portfolio
|
Q1 2025
Reduced 16.27%
|
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
119,113
shares
|
$72,658
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
119,113
shares
|
$72,658
0.0% of portfolio
|
Q1 2024
Added 4.41%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
May 15, 2025 Q1 2025 |
115,867
shares
|
$70,678
0.01% of portfolio
|
Q1 2025
Reduced 11.23%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
105,177
shares
|
$64,157
0.0% of portfolio
|
Q1 2024
Reduced 77.2%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
104,435
shares
|
$63,705
0.0% of portfolio
|
Q1 2025
Reduced 47.29%
|
|
|
Ea Series Trust
Havertown, PA |
Jul 27, 2023 Q2 2023 |
98,952
shares
|
$60,360
0.01% of portfolio
|
Q2 2023
New holding
|
|
|
Velan Capital Investment Management LP
Alpharetta, GA |
May 15, 2025 Q1 2025 |
97,000
shares
|
$59,170
0.05% of portfolio
|
Q1 2025
Added 38.57%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
May 15, 2025 Q1 2025 |
95,434
shares
|
$58,214
0.0% of portfolio
|
Q1 2025
Reduced 58.35%
|
|
|
Xtx Topco LTD
London, X0 |
May 07, 2025 Q1 2025 |
93,154
shares
|
$56,823
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Empowered Funds, LLC
|
May 16, 2025 Q1 2025 |
91,234
shares
|
$55,652
0.0% of portfolio
|
Q1 2025
Reduced 34.09%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
83,084
shares
|
$50,681
0.0% of portfolio
|
Q1 2025
Added 84.14%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
82,727
shares
|
$50,463
0.0% of portfolio
|
Q1 2025
Reduced 56.34%
|
|
|
Rhumbline Advisers
Boston, MA |
May 29, 2025 Q1 2025 |
80,917
shares
|
$49,359
0.0% of portfolio
|
Q4 2024
Added 3.91%
|
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
63,918
shares
|
$38,989
0.0% of portfolio
|
Q1 2025
Reduced 31.5%
|
|
|
Alliancebernstein L.P.
New York, NY |
May 15, 2025 Q1 2025 |
47,780
shares
|
$29,145
0.0% of portfolio
|
Q4 2024
Reduced 0.21%
|
|
|
Intech Investment Management LLC
West Palm Beach, FL |
May 20, 2025 Q1 2025 |
44,010
shares
|
$26,846
0.0% of portfolio
|
Q1 2025
Added 85.51%
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
43,197
shares
|
$26,350
0.0% of portfolio
|
Q1 2025
Reduced 11.03%
|
|
|
Sg Americas Securities, LLC
|
Apr 15, 2025 Q1 2025 |
43,028
shares
|
$26,247
0.0% of portfolio
|
Q1 2025
Added 14.33%
|
|
|
Aaron Wealth Advisors LLC
|
Jul 09, 2025 Q2 2025 |
38,259
shares
|
$23,337
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Mirae Asset Global Etfs Holdings Ltd.
Central, K3 |
May 15, 2025 Q1 2025 |
37,012
shares
|
$22,577
0.0% of portfolio
|
Q1 2025
Added 4.17%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
31,750
shares
|
$19,367
0.0% of portfolio
|
Q1 2025
Reduced 44.04%
|
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
27,207
shares
|
$16,596
0.0% of portfolio
|
Q4 2024
Reduced 7.26%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
26,958
shares
|
$16,444
0.0% of portfolio
|
Q1 2025
Reduced 55.64%
|
|
|
First Manhattan CO
New York, NY |
May 15, 2025 Q1 2025 |
26,000
shares
|
$15,860
0.0% of portfolio
|
Q1 2022
Added 225.0%
|